NKGEN BIOTECH INC (NKGN:OTCMKTS)
$0.0021 0.0001 (5%)
Analysed NKGEN BIOTECH INC (NKGN:OTCMKTS) News Sources
NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.
03-12-2025
yahoo.com
NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board
22-01-2026
yahoo.com
NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
23-03-2026
yahoo.com
NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
09-04-2026
yahoo.com
NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment
19-05-2026
yahoo.com
NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions
02-07-2026
yahoo.com
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
10-09-2026
yahoo.com
What is the current price of NKGEN BIOTECH INC (NKGN:OTCMKTS)?
The current price of NKGEN BIOTECH INC (NKGN:OTCMKTS) is $0.0021.
NKGEN BIOTECH INC (NKGN:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NKGEN BIOTECH INC (NKGN:OTCMKTS) since the previous trading day is $0.0001.
NKGEN BIOTECH INC (NKGN:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NKGEN BIOTECH INC (NKGN:OTCMKTS) since the previous trading day is 5%.
What is the most recent average sentiment score for NKGEN BIOTECH INC (NKGN:OTCMKTS)?
The most recent average sentiment score for NKGEN BIOTECH INC (NKGN:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for NKGEN BIOTECH INC (NKGN:OTCMKTS)?
The most recent sentiment for NKGEN BIOTECH INC (NKGN:OTCMKTS) is .
SEC-8K** Filing Available For NKGEN BIOTECH INC (NKGN:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.